喉癌手术患者血清肝细胞生长因子和血清中细胞角蛋白18水平对患者预后的影响

王艳婷; 李雅琼; 袁浩展

doi:10.13201/j.issn.1001-1781.2018.23.006

喉癌手术患者血清肝细胞生长因子和血清中细胞角蛋白18水平对患者预后的影响

- 咸阳市第一人民医院耳鼻咽喉头颈外科(陕西咸阳, 712000)

详细信息

通讯作者: 袁浩展, E-mail:yuanhz2232@163.com

中图分类号: R739.65

收稿日期: 2018-08-31

Effect of serum HGF and CK18 in patients with laryngeal cancer on postoperative prognosis

- Department of Otorhinolaryngology, the First People's Hospital of Xianyang, Xianyang, 712000, China

More Information

Corresponding author: YUAN Haozhan, E-mail: yuanhz2232@163.com

Received Date: 31 August 2018

摘要

摘要: 目的: 探讨喉癌患者血清中细胞角蛋白18(CK18)和肝细胞生长因子(HGF)与患者肿瘤分期及预后的相关性。方法: 选取200例喉癌患者,均给予手术治疗,采集血样检测CK18及HGF水平,定期随访采集患者术后相关资料。结果: 中低分化程度、肿瘤分级、临床分期较高的患者血清CK18和HGF浓度显著高于高分化程度、肿瘤分级较低、临床分期较低的患者,差异有统计学意义(P<0.05)。高CK18组喉癌患者5年期生存率(69.9%)显著低于低CK18组患者(92.3%),2组比较差异有统计学意义(P<0.05);高HGF组喉癌患者5年期生存率(71.1%)显著低于低HGF组患者(94.2%),差异有统计学意义(P<0.05)。单因素分析结果显示肿瘤类型、分化程度、T分级、N分级、临床分期影响喉癌患者生存率;Cox回归模型分析表明高CK18与高HGF水平是预后的危险因素[CK18 HR:2.594(1.558~4.318);P<0.01,HGF HR:2.671(1.605~4.446);P<0.01]。结论: 血清CK18和HGF水平可作为喉癌预后和疾病监测的生物标志物。
- 肝细胞生长因子 /
- 细胞角蛋白18 /
- 喉肿瘤 /
- 生物标记物
Abstract: Objective: To investigate the correlation between the levels of serum cytokeratin 18 (CK18) and hepatocyte growth factor (HGF) and tumor stage and prognosis in patients with laryngeal carcinoma. Method: Patients with laryngeal cancer who were admitted to our hospital from January 2012 to December 2013 were enrolled. Blood samples were collected for CK18 and HGF detection, and postoperative prognosis data were collected at regular follow-up.Result: The serum CK18 and HGF concentration of patients with poorly differentiated tumor, high tumor grade and clinical stage were significantly higher than those with well-differentiated tumor, low tumor grade and low clinical stage (P<0.05). The 5-year survival rate (69.9%) of patients with laryngeal cancer in the high CK18 group was significantly lower than that in the low CK18 group (92.3%) (P<0.05), and the 5-year survival rate (71.1%) of patients with laryngeal cancer in the high HGF group was significantly lower than that in the low HGF group (94.2%) (P<0.05). The results of univariate analysis showed that tumor type, differentiation, T grade, N grade and clinical stage affected the survival rate of patients with laryngeal cancer. Cox regression model analysis showed high CK18 and high HGF levels were risk factors for poor prognosis[CK18 HR:2.594 (1.558-4.318); P<0.001, HGF HR:2.671 (1.605-4.446); P<0.001].Conclusion: The results suggested that serum CK18 and HGF levels can be used as prognostic and disease monitoring biomarkers for laryngeal cancer.
- HGF /
- CK18 /
- laryngeal neoplasms /
- biomarkers

HTML全文

参考文献(16)

[1]	代丽丽, 刘亭彦, 周雪华, 等.IL-6, STAT3表达对喉癌患者预后影响因素研究[J].中国现代医生, 2013, 51 (19):37-38.
[2]	罗何三, 吴盛喜, 许鸿鹞, 等.术前放疗加手术与单纯手术治疗喉癌生存率比较的Meta分析[J].肿瘤学杂志, 2016, 22 (11):934-941.
[3]	邢鑫, 张自森, 郭彦伟, 等.血清骨桥蛋白, 癌胚抗原及CK18的表达对胃癌的诊断价值[J].郑州大学学报 (医学版), 2018, 53 (2):221-224.
[4]	ABDULHUSSAIN M M.Immunohistochemical Study of CK18 Expression In Head and Neck Squamous Cell Carcinoma[J].Diyala J Med, 2016, 10:9-15.
[5]	李思文, 夏旭, 胡宁东, 等.肝细胞生长因子对非小细胞肺癌侵袭和迁移的影响[J].广东医学, 2017, 38 (2):173-177.
[6]	HAO N B, TANG B, WANG G Z, et al.Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis[J].Cancer Lett, 2015, 361:57-66.
[7]	WANG L, XU Y, YU Q, et al.H-RN, a novel antiangiogenic peptide derived from hepatocyte growth factor inhibits inflammation in vitro and in vivo through PI3K/AKT/IKK/NF-κB signal pathway[J].Biochem Pharmacol, 2014, 89:255-265.
[8]	LIU W W, WANG H X, YU W, et al.Treatment of silicosis with hepatocyte growth factor-modified autologousbone marrow stromal cells:a non-randomized study with follow-up[J].Genet Mol Res, 2015, 14:10672-10681.
[9]	WANG C, YOU X, JIANG C, et al.Hepatocyte growth factor upregulates nexilin gene expression incardiomyocytes via JNK pathway[J].Genet Mol Res, 2014, 13:4976-4782.
[10]	杜灵彬, 毛伟敏, 万青, 等.中国2003-2007年喉癌发病率和死亡率分析[J].中华流行病学杂志, 2014, 33 (4):395-398.
[11]	陶春花.护理干预对喉癌患者围术期心理影响的研究[J].重庆医学, 2014, 43 (13):1669-1670.
[12]	PEDUK S, TATAR C, DINCER M, et al.The Role of Serum CK18, TIMP1, and MMP-9 Levels in Predicting R0 Resection in Patients with Gastric Cancer[J].Dis Markers, 2018, 2018:5604702.
[13]	KILIC-BAYGUTALP N, OZTURK N, ORSAL-IBISOGLU E, et al.Evaluation of serum HGF and CK18 levels in patients with esophageal cancer[J].Genet Mol Res, 2016, 15.
[14]	SANTAMARA L, INGELMO I, SINUES B, et al.Quantification of the heterogeneity of cytokeratin 18immunoexpression in prostate adenocarcinoma and normal prostate:Global andlocalfeatures[J].Histol Histopathol, 2018, 33:1099-1110.
[15]	贾颖, 陈兴国.HGF/c-Met信号途径与肿瘤关系的研究进展[J].山东医药, 2015, 55 (41):101-104.
[16]	李建民, 郑慧媛, 冶娟, 等.喉鳞癌中肝细胞生长因子和间质表皮转化因子的表达及意义[J].中国老年学杂志, 2016, 24 (12):6173-6174.